New hope for kids with Crohn's: drug trial targets gut healing
Disease control
Not yet recruiting
This study tests a new medicine called afimkibart in 100 children aged 2 to 17 with moderate to severe Crohn's disease. The goal is to see if it can reduce symptoms and heal the gut lining. Participants will receive either the drug or a placebo, and the study lasts for several mo…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 29, 2026 02:22 UTC